Major change in the use of antibiotics following a national programme: Swedish strategic programme for the rational use of antimicrobial agents and surveillance of resistance (STRAMA)

Scandinavian Journal of Infectious Diseases

Volumn 31, Issue 2, 1999, Pages 191-195

  Mölstad, Sigvard ^a,b,d   Cars, Otto ^c  

^a LUND UNIVERSITY   (Sweden)

^b Network for Pharmacoepidemiology Foundation   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d Primary Health Care   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; MACROLIDE;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG USE; HOSPITAL INFECTION; INFECTION; MINIMUM INHIBITORY CONCENTRATION; PRESCRIPTION; RESPIRATORY TRACT INFECTION; STATISTICS; STREPTOCOCCUS PNEUMONIAE; SWEDEN;

CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; GOVERNMENT PROGRAMS; HUMANS; INFANT; INFANT, NEWBORN; PENICILLIN RESISTANCE; PENICILLIN V; PENICILLINS; PNEUMOCOCCAL INFECTIONS; RESPIRATORY TRACT INFECTIONS; SENTINEL SURVEILLANCE; STREPTOCOCCUS PNEUMONIAE; SWEDEN;

EID: 0042623215     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655499750006263     Document Type: Article

References (34)

1. Neu HC. The crisis in antibiotic resistance. Science 1992; 257: 1064-73.
2. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White JP, Nicolas-Chanoin MH, et al. The prevalence of nosocomial infection in intensive care units in Europe. JAMA 274: 639-44, 1995.
3. Felmingham D, Grunberg RN and The Alexander Project Group. A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: The Alexander Project. J Antimicrob Chemother 38 Suppl A: 1-57, 1996.
4. Cars O. Colonisation and infection with resistant gram-positive cocci. Epidemiology and risk factors. Drugs 1997; 54 (Suppl. 6): 4-10.
5. Dowell SF, Marcy M, Phillips WR, Gerber MA, Schwartz B. Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections. Pediatr. 1998; 101: 163-5.
6. Hahnberger H, Nilsson LE and the Swedish Study Group. High frequency of antibiotic resistance among Gram-negative isolates in intensive care units at 10 Swedish hospitals. Clin Microbiol Infect 3: 208-15, 1997.
7. Torell E, Fredlund H. Törnquist E, Myhre EB, Sjöberg L, Sundsfjord A. Intrahospital spread of Vancomycin-resistant Enterococcus faecium in Sweden. Scand. J. Infect. Dis. 1997: 29: 259-63.
8. Olsson-Liljequist B, Burman LG, Kallings I. Swedish Respiratory tract Group. Antibiotic susceptibility of upper respiratory tract pathogens in Sweden: a seven year follow-up study including Loracarbef. Scand. J. Infect. Dis. 1992; 24: 485-93.
9. Forsgren A, Walder M. Antimicrobial susceptibility of bacterial isolates in south Sweden including a 13-year follow-up study of some respiratory tract pathogens. APMIS 1994; 102: 227-35.
10. Ekdahl K, Camme C. Increasing resistance to penicillin in Streptococcus pneumoniae in southern Sweden. Scand. J. Infect. Dis. 1995; 26: 485-93.
11. Ekdahl K, Ahlinder I, Hansson HB, Melander E, Mölstad S, Söderström M, et al. Duration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: experiences from the South Swedish Pneumococcal Intervention Project. Clin. Inf. Dis. 1997; 25: 1113-7.
12. Melander E, Ekdahl K, Hansson HB, Kamme C, Laurell M, Nilsson P, Persson K, Söderström M, Mölstad S. Introduction and clonal spread of penicillin-and trimethoprim sulfamethoxazole-resistant Streptococcus pneumoniae, serotype 9V, in southern Sweden. Microb. Drug Resist. 1998; 1: 71-8.
13. Ekdahl K, Hansson HB, Mölstad S, Söderström M, Walder M, Persson K. Limiting the spread of penicillin-resistant Streptococcus pneumoniae: experiences from the South Swedish Pneumococcal Intervention Project. Microb. Drug Resist. 1998; 4: 99-105.
14. Yearly statistical reports by the National Corporation of Pharmacies in Sweden (Apoteksbolaget. Stockholm); 1985-1997.
15. Nordic Statistics on Medicines. Nordic Council on Medicine, Nordiska Läkemedelsnämnden. Uppsala, Sweden.
16. Antimicrobial susceptibility testing in Sweden. Scand J Infect Dis 1997; Suppl 105: 3-31.
17. Treatment of acute infections of the respiratory tract in Primary Health Service. Workshop. Uppsala, Sweden: Medical Products Agency (Läkemedelsverket), 1995.
18. Diagnosis-prescription survey by the National Corporation of Pharmacies in Sweden. Stockholm: Apoteksbolaget, 1988-1994.
19. Howie JGR. Some non-bacterial determinants and implications of antibiotic use in upper respiratory tract illness. Scand J Infect Dis, 68-72, 1983.
20. Mölstad S. Antibiotic usage and betalactamase production in respiratory tract bacteria. Thesis. Lund, Sweden: University of Lund, 1990.
21. Harvey KJ, Stewart R, Hemming M, Naismith N, Moulds RFW. Educational antibiotic advertising. Med. J. Austr. 1986: 145: 28-32.
22. Friis H, Bro F, Mabeck CE, Vejlsgaard R. An information campaign-an important measure in controlling the use of antibiotics. J. Antimicrob. Chemother. 1989: 24: 993-9.
23. Needham A, Brown M, Freeborn S. Introduction and audit of a general practice antibiotic formulary. J. R. Coll. Gen. Pract. 1988; 38: 166-7.
24. Midtvedt T, Bruusgaard D. 'Anti-infectives for systemic use'. In: Drug utilization in Norway during the 1970s-increases, inequalities, innovations, Nor Med Depot, Oslo, 1983.
25. McGavock H. Some patterns of prescribing by urban general practitioners. Br. Med. J. 1988; 296: 900-2.
26. Mölstad S, Ekdahl A, Hovelius B, Thimansson H. Antibiotics prescription in primary care: a five-year follow-up of an educational programme. Fam. Pract. 1994; 11: 282-6.
27. Bentzen N. Medical audit - the APO-method in general practice. Scand. J. Prim. Health Care 1993; 11: 13-8.
28. Seppälä H, Klaukka T, Vuopio-Varkila J, Muotila A, Helenius H, Lager K. et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N. Engl. J. Med. 1997; 337: 441-6.
29. Kristinsson KG, Hjalmarsdottir MA, Gudnason TH. Continued decline in the incidence of penicillin nonsusceptible pneumococci in Iceland. 38th Interscience Conference on antimicrobial agents and chemotherapy, San Diego, Calif. abstr no 622, 1998.
30. Baquero F, Martinez-Beltrán J, Loza E. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J. Antimicrob. Chemother. 1991; 28 (Suppl. C): 31-8.
31. Gomez J, Ruiz-Gomez J, Hernandez-Cardona JL, Nunez ML, Canteras M, Valdes M. Antibiotic resistance patterns of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a prospective study from Murcia. Spain 1983-1992. Chemother 40: 387-391, 1994.
32. Arason VA, Kristinsson K, Sigurdsson J, Stefansdottir G, Mölstad S, Gudmundsson S. Do antimicrobials increase the carriage rate of penicillin resistant S.pneumoniae? Cross sectional prevalence study. Br. Med. J. 1996; 313: 387-91.
33. Kristinson KG. Epidemiology of penicillin resistant pneumococci in Iceland. Microb. Drug, Resist. Mech. E. Dis. 1995; 1: 121-5.
34. Mölstad S, Arvidsson E, Eliasson I, Hovelius B, Kamme C. Schalén C. Production of betalactamase by respiratory tract bacteria in children: Relationship to antibiotic use. Scand. J. Prim. Health Care 1992; 10: 16-20.